17-Oxo dexamethasone
CAS: 1880-61-1
Ref. 3D-FO26646
5g | 4.058,00 € | ||
1mg | 232,00 € | ||
2mg | 310,00 € | ||
5mg | 436,00 € | ||
10mg | 453,00 € |
Produktinformation
- 9-Fluoro-11-hydroxy-16-methyl-(11β,16α)androsta-1,4-diene-3,17-dione9-Fluoro-11β-hydroxy-16α-methyl androsta-1,4-diene-3,17-dione NSC 50909
- 9-Fluoro-11b-hydroxy-16a-methyl Androsta-1,4-diene-3,17-dione
- Nsc 50909
- 9-Fluoro-11-hydroxy-16-methyl-(11b,16a ) Androsta-1,4-diene-3,17-dione
- 9alpha-Fluoro-11beta-hydroxy-16alpha-methyl-1,4-androstadiene-3,17-dio ne
- 9-Fluoro-11-hydroxy-16a-methyl Androsta-1,4-diene-3,17-dione
- 9-Fluoro-11-hydroxy-16-methyl-(11,16a ) Androsta-1,4-diene-3,17-dione
- (11Beta,16Alpha)-9-Fluoro-11-Hydroxy-16-Methylandrosta-1,4-Diene-3,17-Dione
- 9-Fluoro-11-Hydroxy-16-Methylandrosta-1,4-Diene-3,17-Dione
17-Oxo dexamethasone is a mixture of 17-hydroxy-6,7-dihydro-17α-methylpregna-1,4,9(11)-triene-3,20-dione and its 3β,5β stereoisomers. It is an oxidation product of dexamethasone that may be formed during the synthesis or storage of this drug. The impurity has been identified by high resolution mass spectrometry. A potent anti tuberculosis drug belonging to the class of rifamycins Rifapentine inhibits bacterial growth by binding to DNA dependent RNA polymerase, thereby preventing transcription and replication. This active form is metabolized through a number of metabolic transformations including hydrolysis by esterases or glucuronidases, oxidation by cytochrome P450 enzymes, reduction by glutathione reductase or conjugation with glucuronic acid. Rifapentine
Chemische Eigenschaften
Technische Anfrage zu: 3D-FO26646 17-Oxo dexamethasone
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.